Evolution News and Research

RSS

Lantheus presents preliminary Phase 2 data of flurpiridaz F18 injection PET MPI at 57th SNM

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced preliminary Phase 2 data describing the methodology used to define an imaging protocol for a one-day rest-stress myocardial perfusion imaging test using its novel investigational PET imaging agent flurpiridaz F 18 injection (formerly known as BMS747158).

10 Jun 2010

Today's multi-touch systems may lead people to MSD: Researchers

The evolution of computer systems has freed us from keyboards and now is focusing on multi-touch systems, those finger flicking, intuitive and easy to learn computer manipulations that speed the use of any electronic device from cell phones to iPads. But little is known about the long-term stresses on our bodies through the use of these systems.

10 Jun 2010

RCSI scientists make breakthrough in understanding human adaptation to high altitude environments

A group of top international scientists including geneticists from the Royal College of Surgeons in Ireland has made a breakthrough in understanding human adaptation to high altitude environments.

9 Jun 2010

Allscripts, Eclipsys announce merger

Allscripts, the leading provider of clinical software, information and connectivity solutions for physicians, and Eclipsys, a leading enterprise provider of solutions and services for hospitals and clinicians, today announced a definitive agreement to merge in an all-stock transaction valued at approximately $1.3 billion.

9 Jun 2010

Gene variant linked to ability of Tibetans to cope with low-oxygen conditions identified

A new study pinpoints the genetic changes that enable Tibetans to thrive at altitudes where others get sick.

8 Jun 2010

Hormone involved in iron metabolism can save mice from deadly acute inflammation: Scientists

In a surprising discovery that someday may lead to new treatments for many inflammatory diseases, University of Utah scientists found that a hormone involved in iron metabolism can save mice from deadly acute inflammation.

8 Jun 2010

Protein p53 becomes activated to control creation of ova and spermatozoids: Study

Protein 53 is very important in protecting against cancer given that it prevents cancer-causing mutations from accumulating and its inactivation is closely linked to the proliferation of tumour cells. UAB lecturer Ignasi Roig participated in the study. Formed by an international research team, the study served to discover that this protein played an unexpected physiological role: it also becomes activated during the formation process of ova and spermatozoids.

8 Jun 2010

GE Healthcare highlights molecular imaging technologies to help clinicians improve patient experiences

Focusing on helping clinicians improve experiences for their patients, GE Healthcare is highlighting an innovative portfolio of molecular imaging technologies and agents at the 57th annual meeting of the Society of Nuclear Medicine, June 5-9, in Salt Lake City.

7 Jun 2010

Caltech biologists pinpoint molecular changes that help allow global spread of resistance to Tamiflu

Biologists at the California Institute of Technology have pinpointed molecular changes that helped allow the global spread of resistance to the antiviral medication Tamiflu (oseltamivir) among strains of the seasonal H1N1 flu virus.

4 Jun 2010

Researchers underscore role of jumping genes in maintaining genetic diversity

Using high-throughput sequencing to map the locations of a common type of jumping gene within a person's entire genome, researchers at the University of Pennsylvania School of Medicine found extensive variation in these locations among the individuals they studied, further underscoring the role of these errant genes in maintaining genetic diversity.

4 Jun 2010

MAXIMUS President to present on challenges that impact efficiency of Medicaid and CHIP

MAXIMUS, a leading provider of government services worldwide, announced today that Bruce Caswell, President and General Manager of MAXIMUS Health Services, will present at the upcoming Fifth National Medicaid Congress in Washington, D.C.

4 Jun 2010

Growth hormone treatment promotes growth in infants with CRF: Study

Infants with chronic renal failure grow slowly, a problem that usually improves with aggressive nutritional therapy. When it doesn't, growth hormone is a safe and effective treatment to promote growth, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology.

4 Jun 2010

SOFAR licenses Immersion's TouchSense haptics technology for use in ALF-X telesurgical robot system

Immersion Corporation, the leading developer and licensor of haptics technology, today announced that SOFAR S.p.A., a leading Italian manufacturer of medical devices for minimally invasive surgery, has obtained a license to Immersion's TouchSense haptics technology for use in its ALF-X (Advanced Laparoscopy through Force Reflection) telesurgical robot system.

2 Jun 2010

EMBL scientists identify two small RNA molecules that ensure red blood cell production

Red blood cells, the delivery men that take oxygen to cells all around the body, have short lives. To keep enough of them in circulation, the human body produces around 2 million of these cells every second - even more in response to challenges like severe blood loss. In a study published today in the Journal of Experimental Medicine, scientists at the European Molecular Biology Laboratory in Monterotondo, Italy, and EMBL's European Bioinformatics Institute in Hinxton, UK, have identified two small RNA molecules which ensure that enough red blood cells are produced efficiently, by fine-tuning a number of different genes involved in this process.

2 Jun 2010

UC Riverside botanist receives BSA Merit Award for outstanding contributions to botanical science

Darleen DeMason, a professor of botany in UC Riverside's Department of Botany and Plant Sciences, has been elected as one of this year's six Botanical Society of America Merit Award recipients.

29 May 2010

CytRx commences Phase 2 clinical trial of bafetinib for high-risk B-cell chronic lymphocytic leukemia

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced initiation of a Phase 2 proof-of-concept clinical trial to evaluate the preliminary efficacy and safety of its oncology drug candidate bafetinib in patients with high-risk B-cell chronic lymphocytic leukemia (B-CLL).

29 May 2010

Diving "feet first" can prevent spinal cord injuries

Matt, a Dearborn, Mich. resident, is featured in an award-winning video "Shattered Dreams," commissioned by the University of Michigan's Department of Neurosurgery as part of an injury prevention effort. Public service announcements based on the video begin airing in southeastern Michigan movie theatres June 4 to spread the message of "feet first" to boaters and swimmers.

27 May 2010

Neurological Institute at University Hospitals receives Neuroscience Center of Excellence designation

The Neurological Institute at University Hospitals has been designated as a Neuroscience Center of Excellence (COE), according to the Neuroscience Center of Excellence Survey sponsored by NeuStrategy, Inc., Chicago. It is the first neurological program in Ohio to receive the Stage 4 - Institute designation.

27 May 2010

UCSF scientists discover new stem cell in developing human brain

UCSF scientists have discovered a new stem cell in the developing human brain. The cell produces nerve cells that help form the neocortex - the site of higher cognitive function -- and likely accounts for the dramatic expansion of the region in the lineages that lead to man, the researchers say.

26 May 2010

Research findings on pediatric ILD published online in PED

An insightful and in-depth presentation of the most up-to-date clinical and research findings and historical perspectives on pediatric interstitial lung disease is presented in a special issue published online ahead of print in Pediatric Allergy, Immunology, and Pulmonology, a peer-reviewed journal published by Mary Ann Liebert, Inc.

26 May 2010

Evolution News and Research

Lantheus presents preliminary Phase 2 data of flurpiridaz F18 injection PET MPI at 57th SNM

Today's multi-touch systems may lead people to MSD: Researchers

RCSI scientists make breakthrough in understanding human adaptation to high altitude environments

Allscripts, Eclipsys announce merger

Gene variant linked to ability of Tibetans to cope with low-oxygen conditions identified

Hormone involved in iron metabolism can save mice from deadly acute inflammation: Scientists

Protein p53 becomes activated to control creation of ova and spermatozoids: Study

GE Healthcare highlights molecular imaging technologies to help clinicians improve patient experiences

Caltech biologists pinpoint molecular changes that help allow global spread of resistance to Tamiflu

Researchers underscore role of jumping genes in maintaining genetic diversity

MAXIMUS President to present on challenges that impact efficiency of Medicaid and CHIP

Growth hormone treatment promotes growth in infants with CRF: Study

SOFAR licenses Immersion's TouchSense haptics technology for use in ALF-X telesurgical robot system

EMBL scientists identify two small RNA molecules that ensure red blood cell production

UC Riverside botanist receives BSA Merit Award for outstanding contributions to botanical science

CytRx commences Phase 2 clinical trial of bafetinib for high-risk B-cell chronic lymphocytic leukemia

Diving "feet first" can prevent spinal cord injuries

Neurological Institute at University Hospitals receives Neuroscience Center of Excellence designation

UCSF scientists discover new stem cell in developing human brain

Research findings on pediatric ILD published online in PED

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News